What other stocks do shareholders of Sequenom own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sequenom investors own include Arch Resources (ARCH) , PotlatchDeltic (PCH) , Illumina (ILMN) , LinnCo (LNCOQ) , Conatus Pharmaceuticals (CNAT) , DryShips (DRYS) , La Jolla Pharmaceutical (LJPC) , NovoCure (NVCR) , Acer Therapeutics (ACER) and Aeterna Zentaris (AEZS) .

NASDAQ:SQNM

Sequenom (SQNM) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free SQNM Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $2.39
▼
$2.39
50-Day Range: N/A
52-Week Range: $0.82
▼
$2.53

Volume: N/A
Average Volume: 1.27 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Sequenom alerts:

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Sequenom Stock (NASDAQ:SQNM)

Sequenom, Inc. is a life sciences company. The Company serves patients and physicians by providing early patient management information. The Company operates through Sequenom Laboratories segment. It conducts its business as a molecular diagnostics clinical laboratory located in San Diego, California and Raleigh-Durham, North Carolina. Its testing focus is on prenatal health that includes molecular-based laboratory developed tests (LDTs). The Company's diagnostic services are provided through its subsidiary, Sequenom Center for Molecular Medicine LLC (SCMM), doing business as Sequenom Laboratories. Sequenom Laboratories develops and validates its tests to be used as a testing service to physicians. Sequenom Laboratories is focused on developing and offering a menu of tests for prenatal continuum of care. The Sequenom Laboratories' test offerings in the prenatal market include MaterniT21 PLUS LDT, HerediT CF test, SensiGene RhD test, VisibiliT test and Test Send-out Agreements.

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SQNM Stock News Headlines

September 9, 2023 | thestreet.com

5 Biotech Stocks Under $10 Set to Soar

July 23, 2023 | thestreet.com

Sequenom Fallout Hits Hedge Funds

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

May 18, 2023 | reuters.com

Latest Markets News

February 27, 2023 | thestreet.com

Sequenom Still Very Good, Just No Longer Perfect

January 7, 2023 | thestreet.com

Past Sequenom Exec Charged with Lying by SEC

October 19, 2022 | streetinsider.com

JUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - StreetInsider.com

October 18, 2022 | prnewswire.com

JUNO DIAGNOSTICS STRENGTHENS THE ORGANIZATION WITH APPOINTMENT OF GINA GRAYUM TO COMMERCIAL LEADERSHIP TEAM - PR Newswire

April 18, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 12, 2022 | globenewswire.com

Prenatal and Newborn Genetic Testing Market to hit US$ 12.70 Billion by 2030 | Exclusive Report by Growth Plus Reports - GlobeNewswire

October 10, 2022 | globenewswire.com

Viral Antigens Market to Reach US$ 0.292 billion by 2030 Size, Shares, Forecasts, and Trends Analysis Report with COVID-19 Impact by Growth Plus Reports - GlobeNewswire

September 23, 2022 | seekingalpha.com

Invitae: Losses & Debt Suggest Bearish Sentiment Is Deserved - Seeking Alpha

September 19, 2022 | businesswire.com

World Non-Invasive Prenatal Testing (NIPT) Pipeline Market Report 2022: Comparative Analysis at Various Stages of Development and Information on Clinical Trials in Progress - ResearchAndMarkets.com - Business Wire

September 7, 2022 | businesswire.com

Ansa Bio Appoints Lorna Neilson, Ph.D. as Chief Business Officer - Business Wire

July 1, 2022 | globenewswire.com

The Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - GlobeNewswire

June 29, 2022 | uk.finance.yahoo.com

The Worldwide Carrier Screening Industry is Expected to Reach $3.64 Billion by 2030 - Yahoo Finance UK

June 23, 2022 | prnewswire.com

New Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - PR Newswire

June 23, 2022 | finance.yahoo.com

New Analysis from Global Industry Analysts Reveals Steady Growth for Genotyping, with the Market to Reach $39.9 Billion Worldwide by 2026 - Yahoo Finance

June 5, 2022 | seekingalpha.com

Laboratory Corp: 15% Reward Asymmetry Under-Reflected, Seeking Exit At $280 Per Share - Seeking Alpha

May 31, 2022 | finance.yahoo.com

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications - Yahoo Finance

May 13, 2022 | law360.com

Fed. Circ. Says LabCorp Missed Chance To Move Patent Row - Law360

April 6, 2022 | prnewswire.com

IDEAYA Biosciences Appoints Catherine Mackey, Ph.D., to its Board of Directors - PR Newswire

March 9, 2022 | businesswire.com

Global Non-invasive Prenatal Testing Market Report 2022: By Type, End User, Instruments, Consumables and Application - ResearchAndMarkets.com - Business Wire

February 7, 2022 | finance.yahoo.com

Ambrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Yahoo Finance

February 7, 2022 | businesswire.com

Ambrx Biopharma Inc. Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - Business Wire

February 7, 2022 | streetinsider.com

Ambrx Biopharma (AMAM) Appoints Paul Maier to Board of Directors and as Chair of the Audit Committee - StreetInsider.com

January 26, 2022 | globenewswire.com

Global Genotyping Assay Market to Reach Over $40.0 Billion by 2028 - GlobeNewswire

See More Headlines

Receive SQNM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sequenom and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: Life Sciences Tools & Services
Current Symbol: NASDAQ:SQNM
CUSIP: 81733740
CIK: 1076481
Web: www.sequenom.com
Phone: +1-858-2029000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

SQNM Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Sequenom own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sequenom investors own include Arch Resources (ARCH), PotlatchDeltic (PCH), Illumina (ILMN), LinnCo (LNCOQ), Conatus Pharmaceuticals (CNAT), DryShips (DRYS), La Jolla Pharmaceutical (LJPC), NovoCure (NVCR), Acer Therapeutics (ACER) and Aeterna Zentaris (AEZS).

This page (NASDAQ:SQNM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sequenom (SQNM) Stock Price, News & Analysis

About Sequenom Stock (NASDAQ:SQNM)

SQNM Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

SQNM Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info